Navitas Semiconductor Corporation Common Stock vs GeneDx Holdings Corp — how do they compare? Navitas Semiconductor Corporation Common Stock trades at $11.24 (market cap $2.97B), while GeneDx Holdings Corp trades at $67.6 (market cap $2.04B). The key difference: Navitas Semiconductor Corporation Common Stock is the larger of the two by market cap, and GeneDx Holdings Corp is more actively traded (659,215 versus 18,229,864). Which is the better fit depends on your goals — on Pluang, investors hold Navitas Semiconductor Corporation Common Stock for 0 Days and GeneDx Holdings Corp for 19 Days on average.
| NVTS | WGS | |
|---|---|---|
Market Cap | $2.97B | $2.04B |
Volume | 18,229,864 | 659,215 |
Sector | Technology | Health |
52-Week High | $31.79 | $167.51 |
52-Week Low | $7.14 | $34.51 |
Typical Hold Time | 0 Days | 19 Days |
Enterprise Value | $2.41B | $2.08B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx (WGS) trades at $68.53, down 4.18% today amid bearish technical signals despite recent positive earnings surprises. The stock shows mixed fundamentals with strong revenue growth to $454M in 2026 but negative profitability metrics including -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target representing 18% upside potential.
The investment case balances strong analyst support and genomic testing market growth against persistent profitability challenges and negative cash flow trends. Key catalysts include Q3 2026 earnings due soon and continued execution on operational improvements, while risks center on margin recovery timeline and competitive pressures in the rapidly evolving genomics space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Navitas Semiconductor designs and markets gallium nitride and silicon carbide power semiconductors. Its products are used in power conversion and charging for data centers, energy infrastructure, and industrial applications.
Read more on NVTS →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →